(Q35202136)

7 August 2017

1 reference

title

Mechanisms of renal hyporesponsiveness to ANP in heart failure (English)

1 reference

7 August 2017

0 references

Charloux A

1

1 reference

7 August 2017

Piquard F

2

1 reference

7 August 2017

Doutreleau S

3

1 reference

7 August 2017

Brandenberger G

4

1 reference

7 August 2017

Geny B

5

1 reference

7 August 2017

1 September 2003

1 reference

European Journal of Clinical Investigation

7 August 2017

1 reference

7 August 2017

33

1 reference

7 August 2017

9

1 reference

7 August 2017

769-778

1 reference

Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin

7 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

The effects of angiotensin II on circulating levels of natriuretic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Therapeutic benefits of increasing natriuretic peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Enhanced natriuretic response to neutral endopeptidase inhibition in heart-transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Potentiation of urinary atrial natriuretic peptide interferes with macula densa function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Attempts to alter the heterogeneous response to ANP in sodium-retaining caval dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Natriuretic peptide signalling: molecular and cellular pathways to growth regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Reduced activity of the NPR-A kinase triggers dephosphorylation and homologous desensitization of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Treatment with darusentan over 21 days improved cGMP generation in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Vasopressin V2 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Physiological effects of vasopressin and atrial natriuretic peptide in the collecting duct.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

Renal endothelin in heart failure and its relation to sodium excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01222.X

10.1046/J.1365-2362.2003.01222.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference